MedPath

A clinical trial to study the effect of dexmeditomidine in two different routes of administration in patients undergoing elective and emergency femur surgeries.

Phase 4
Conditions
Health Condition 1: null- Patients who have got femur bone frature
Registration Number
CTRI/2016/03/006757
Lead Sponsor
Ranjith Kumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
78
Inclusion Criteria

1)Elective and emergency Femur bone surgeries,

2)American society of Anesthesiologist 1,2,3 physical status patients.

Exclusion Criteria

1)Coagulation disorders

2)Previous femoral bypass surgeries

3)Inflammation and infection over injection sites

4)Allergic to local anesthetics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Requirement of Perioperative analgesic agents <br/ ><br> <br/ ><br>Duration of analgesiaTimepoint: Requirement of perioperative analgesic agents at the time of skin incision of the surgery, requirement of analgesic agents intraoperatively and 24 hours post operatively.
Secondary Outcome Measures
NameTimeMethod
Perioperative hemodynamic outome <br/ ><br> <br/ ><br>Side effect profileTimepoint: 1.5 Years
© Copyright 2025. All Rights Reserved by MedPath